Company Filing History:
Years Active: 2020
Title: Innovations of Dana Carmel Hammel in Cannabidiol Prodrugs
Introduction
Dana Carmel Hammel is an accomplished inventor based in Georgetown, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the use of cannabidiol prodrugs. His innovative work aims to enhance drug delivery systems for various medical applications.
Latest Patents
Hammel holds a patent for the "Use of Cannabidiol Prodrugs in Pharmaceutical Compositions." This patent describes the development of cannabidiol prodrugs utilized in pharmaceutical compositions, as well as microneedle drug delivery systems. These systems are designed to deliver active agents, such as cannabidiol and its prodrugs, effectively to mammals. The patent also outlines methods for using microneedle transdermal or topical drug delivery systems in treating diseases, including pancreatitis and pancreatic cancer.
Career Highlights
Dana Hammel is currently associated with Zynerba Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that improve the efficacy of drug delivery systems.
Collaborations
Hammel collaborates with notable colleagues, including Audra Lynn Strinchcomb and Stan Lee Banks, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Dana Carmel Hammel's contributions to the field of pharmaceuticals, particularly through his patent on cannabidiol prodrugs, showcase his commitment to innovation and improving healthcare solutions. His work has the potential to significantly impact the treatment of serious medical conditions.